TriVascular brings in $60mm through its Series C round

TriVascular Inc. (stents for endovascular aortic repair) has raised $60mm through its Series C venture round. New backer Pinnacle Ventures led the financing and was joined by current shareholders New Enterprise Associates, Delphi Ventures, MPM Capital, and Kearny Venture Partners. Pinnacle and NEA will each contribute one board member. The money will support the launch TriVascular's Ovation abdominal stent graft system in Europe, clinical research performed on three continents for projects that include the Ovation thoracic stent graft system, and next-generation product development. The company has brought in $155mm since it was restarted in 2008 after being acquired from Boston Scientific.